Therapeutic Effect of Azithromycin on Clinical Gynecological Mycoplasma Infection
Objective: To explore the therapeutic effect of Azithromycin on gynecological mycoplasma infection. Method: Forty patients with gynecological mycoplasma infection who underwent examination and treatment in our hospital from June 2021 to June 2022 were selected as the study subjects. These 40 patients were divided into a control group and an experimental group, with 20 patients in each group. Among them, the experimental group was treated with Azithromycin, and the patients in the control group were treated with cefoxitin sodium. The effects, satisfaction and adverse reactions of the two groups were compared. Result: Through experimental comparison, it can be seen that the total effective rate of treatment in the experimental group is better than that in the control group, and the difference between the two is statistically significant (P<0.05); After receiving treatment, the IL-10 and TNF levels in two experimental groups of patients- Î±,Â CRP and other levels all decreased, and in the observation group, patients' IL-10 and TNF- Î±.Â The CRP level will be lower than the control group, and the difference between the two is statistically significant (P<0.05). After the experiment, the satisfaction of patients in the observation group will be higher than that in the control group, and the difference between the two is statistically significant (P<0.05). Conclusion: The treatment effect of Azithromycin for clinical gynaecological mycoplasma infection will be better. With this treatment method, the clinical symptoms of patients can be effectively improved. At the same time, the treatment compliance and satisfaction of patients can be further improved, and the probability of various adverse reactions can be reduced. It can be popularized and applied to clinical practice.
 Cai JR. Observation on the effect of Azithromycin combined with Fukangjian mixture in the treatment of mycoplasma infected pelvic inflammation. Internal Medicine, 2018.
 Wu B, Xu J, Ma XF. The efficacy of Yinjia tablet combined with Azithromycin in the treatment of pelvic inflammatory diseases infected with mycoplasma and its influence on the level of inflammatory factors and immune function; Infectious Disease Information, 2018.
 Liu KN, Qin CM, Shang YM. Research on Drug Resistance of Mycoplasma Pneumoniae in Hospitals in the Last Five Years. Chinese Journal of Hospital Infection, 2018.
 Xie J. et al. Detection and drug resistance analysis of mycoplasma in Vaginal discharge of gynecological patients in Xi'an. Journal of Modern Medical laboratory, 2017.
Copyright (c) 2023 Wenzhi Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.